North America Cyclodextrins in Pharma Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Published Report
  • Sep 2021
  • North America
  • 350 Pages
  • No of Tables: 47
  • No of Figures: 49

North America Cyclodextrins in Pharma Market, Type (Β Cyclodextrin, 2-Hydroxypropyl-Β-Cyclodextrin, Α Cyclodextrin, γ-Cyclodextrin, Randomly Methylated Β-Cyclodextrin, Sulfobutylether Β-Cyclodextrin, 2-Hydroxypropyl-Γ-Cyclodextrin), Structure Segment (Cyclodextrin Conjugates, Mucoadhesive Drug Carriers, Cyclodextrin Associates, Amphiphilic Cyclodextrins, Others), Nature(Hydrophilic, Hydrophobic ), Form( Solid, liquid),Application(drug solubility and dissolution, drug bioavailability, drug safety, drug stability, others), Therapeutics area(pain management, cardiovascular diseases, behavioral disorder, cancer therapy, rheumatoid arthritis, epilepsy, niemann pick disease type c (NPC), others), Distribution channels(direct tender, retail sales, others), Country (U.S., Canada, Mexico) – Industry Trends & Forecast to 2027.     

North America Cyclodextrins in Pharma Market

 

Market Analysis and Insights: North America Cyclodextrins in Pharma Market 

Cyclodextrins in Pharma Market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 2.9% in the forecast period of 2020 to 2027 and is expected to reach USD 61,069.70 thousand by 2027 from USD 48,661.21 thousand in 2019. Increasing bio availability of poor water soluble drugs, increases drug stability, use of cyclodextrin in drug delivery are the major drivers which propelled the demand of the market in the forecast period.

Cyclodextrin are a family of complex cyclic sugars which consists complex macrocyclic ring of glucose subunits that are held together by alpha-1,4 glycosidic bonds. The enzymatic decomposition of a starch between simple molecules leads to the formation of cyclodextrin. The wider use of cyclodextrin can be observed in as solvent additives drug delivery, pharmaceutical and chemical industries. Among major uses, cyclodextrin utilized in encapsulation of hydrophobic drug molecules into biological system which also helps to improve water solubility, stability and bioavailability of drugs.

Cyclodextrin demand has increased as compared to the precise year with its more use in pharmaceutical industry for drug formulations as additives. The significant use of cyclodextrin in renal disseses and growing healthcare expenditure also creating high demand of cyclodextrin. In addition demand of cyclodextrin in COVID 19 treatment is likely to be seen in antiviral drug formulation based on research, thus leading to high demand o cyclodextrin. However, stringent rules and regulations along with barriers of conduction diagnostics test expected to slow down the growth of the cyclodextrin market market in the forecasted period.

The Cyclodextrins in pharma Market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America Cyclodextrins in Pharma MarketNorth America Cyclodextrins in Pharma Market Scope and Market Size

 Cyclodextrins in pharma Market is segmented on the basis of type, structure, nature, form, application, therapeutic areas and distribution channel.

 The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the market is segmented into Β Cyclodextrin, 2-Hydroxypropyl-Β-Cyclodextrin, Α Cyclodextrin, γ-Cyclodextrin, Randomly Methylated Β-Cyclodextrin, Sulfobutylether Β-Cyclodextrin, 2-Hydroxypropyl-Γ-Cyclodextrin. In 2020, B cyclodextrins is expected to dominate in cyclodextrins in pharma market due to their use in the pharmaceutical field due to their ability to improve the solubility and stability of drugs with complex solid formation.
  • On the basis of structure segment market is segmented into Cyclodextrin Conjugates, Mucoadhesive Drug Carriers, Cyclodextrin Associates, Amphiphilic Cyclodextrins, Others. In 2020, Cyclodextrin conjugated segment holds highest share in cyclodextrin market due to its ability to stabilize the drug.
  • On the basis of nature, the market is segmented into Hydrophilic, Hydrophobic. In 2020, the hydrophobic component segment holds highest share in cyclodextrin market due to the increased organic supply of water-soluble drugs.
  • On the basis of form, the market is segmented into solid, liquid. In 2020, solid component is expected to dominate cyclodextrins in the pharmaceutical market due to increased innovation in the pharmaceutical industry.
  • On the basis of application, the market is segmented into drug solubility and dissolution, drug bioavailability, drug safety, drug stability, others. In 2020, drug solubility and dissolution are expected to dominate the market due to the presence of cyclodextrins for various administrations, such as oral, gastrointestinal, top-of-the-line drugs to increase drug efficacy.
  • On the basis of therapeutic areas, the market is segmented into pain management, cardiovascular diseases, behavioral disorder, cancer therapy, rheumatoid arthritis, epilepsy, niemann pick disease type c (NPC), others. In 2020, pain management plays a large role due to the increased incidence of pain management and increased awareness and concern regarding pain management in people.
  • On the basis of distribution channel, the market is segmented into direct tender, retail sales, others. In 2020, direct tender dominates countries in the market where cyclodextrins used in pharmaceutical production are available through direct tenders and this makes it possible to purchase cyclodextrins in bulk.

North America Cyclodextrins in Pharma MarketCyclodextrins in Pharma Market Country Level Analysis

The cyclodextrins in pharma market is analysed and market size information is provided by type, structure, nature, form, application, therapeutic areas and distribution channel.

The country covered in the cyclodextrins in pharma market report is U.S., Canada, and Mexico.   

  • In North America market, the United States dominates the North American equipment market due to the large number of companies, R&D capabilities and the presence of new cyclodextrin lead drugs in pharmacology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data. 

Increasing Bio Availability of Poor Water Soluble Drugs and Increases Drug Stability Leads the Demand of Cyclodextrin Based Products Are Boosting the Market Growth of Cyclodextrins in Pharma

Cyclodextrins in pharma market also provides you with detailed market analysis for every country growth in Cyclodextrins in pharma industry with Cyclodextrins in pharma drugs and diagnostic tools sales, impact of advancement in the Cyclodextrin in pharma treatment technology and changes in regulatory scenarios with their support for the Cyclodextrin in pharma market. The data is available for historic period 2010 to 2018. 

Competitive Landscape and Cyclodextrins in Pharma Market Share Analysis

Cyclodextrin in pharma market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Cyclodextrins in pharma market.

The major companies which are dealing in the Cyclodextrins in pharma are Cambrex Corporation, Cayman Chemical, Wellona Pharma, Wacker Chemie AG, Roquette Frères, Merck KGaA, Midas Pharma GmbH, Ligand Pharmaceuticals Incorporated, Cyclo Therapeutics, Inc., Zibo Qianhui biological technology co., ltd, among more. Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the Cyclodextrins in pharma market.

For instance,

  • In February 2020, Merck KGaA signed a partnership agreement with AMCM for 3D tablet printing. This agreement is aimed at the good manufacturing, manufacturing and marketing of tablet formatting. This partnership will help the company increase its research and product sales.
  • In April 2019, Cambrex Corporation completed the construction of a powerful API plant in Charles City, IA. This new manufacturing area has helped the company grow their business as a whole.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company market in the Cyclodextrin in pharma market which also provides the benefit for organization to improve their offering for Cyclodextrins in pharma.

Customization Available: North America Cyclodextrins in Pharma Market 

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 CURRENT ANTIVIRAL DRUGS TESTED OR IN DEVELOPMENT FOR TREATMENT OF COVID-19 AND PROPOSED CYCLODEXTRINS FOR FORMULATION ENHANCEMENT

TABLE 2 PRICE OF 25G BETA-CYCLODEXTRIN

TABLE 3 PRICE OF 100G BETA-CYCLODEXTRIN

TABLE 4 NORTH AMERICA CYCLODEXTRINS IN PHARMA MARKET, BY TYPE, 2017-2027 (USD THOUSAND)

TABLE 5 NORTH AMERICA CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE 2019-2027 (USD THOUSAND)

TABLE 6 NORTH AMERICA CYCLODEXTRIN CONJUGATES IN CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 7 NORTH AMERICA MUCOADHESIVE DRUG CARRIERS IN CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 8 NORTH AMERICA CYCLODEXTRIN ASSOCIATES IN CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 9 NORTH AMERICA AMPHIPHILIC CYCLODEXTRINS IN CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 10 NORTH AMERICA CYCLODEXTRINS IN PHARMA MARKET, BY FORM, 2019-2027 (USD THOUSAND)

TABLE 11 NORTH AMERICA CYCLODEXTRINS IN PHARMA MARKET, BY NATURE, 2019-2027 (USD THOUSAND)

TABLE 12 NORTH AMERICA CYCLODEXTRINS IN PHARMA MARKET, BY APPLICATION, 2019-2027 (USD THOUSAND)

TABLE 13 NORTH AMERICA CYCLODEXTRINS IN PHARMA MARKET, BY THERAPEUTIC AREAS, 2017-2027 (USD THOUSAND)

TABLE 14 NORTH AMERICA CYCLODEXTRINS IN PHARMA MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 (USD THOUSAND)

TABLE 15 U.S. CYCLODEXTRINS IN PHARMA MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 16 U.S. CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 17 U.S. CYCLODEXTRIN ASSOCIATES IN CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 18 U.S. CYCLODEXTRIN CONJUGATES IN CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 19 U.S. MUCOADHESIVE DRUG CARRIERS IN CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 20 U.S. AMPHIPHILIC CYCLODEXTRINS IN CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 21 U.S. CYCLODEXTRINS IN PHARMA MARKET, BY NATURE, 2018-2027 (USD THOUSAND)

TABLE 22 U.S. CYCLODEXTRINS IN PHARMA MARKET, BY FORM, 2018-2027 (USD THOUSAND)

TABLE 23 U.S. CYCLODEXTRINS IN PHARMA MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 24 U.S. CYCLODEXTRINS IN PHARMA MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)

TABLE 25 U.S. CYCLODEXTRINS IN PHARMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 26 CANADA CYCLODEXTRINS IN PHARMA MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 27 CANADA CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 28 CANADA CYCLODEXTRIN ASSOCIATES IN CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 29 CANADA CYCLODEXTRIN CONJUGATES IN CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 30 CANADA MUCOADHESIVE DRUG CARRIERS IN CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 31 CANADA AMPHIPHILIC CYCLODEXTRINS IN CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 32 CANADA CYCLODEXTRINS IN PHARMA MARKET, BY NATURE, 2018-2027 (USD THOUSAND)

TABLE 33 CANADA CYCLODEXTRINS IN PHARMA MARKET, BY FORM, 2018-2027 (USD THOUSAND)

TABLE 34 CANADA CYCLODEXTRINS IN PHARMA MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 35 CANADA CYCLODEXTRINS IN PHARMA MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)

TABLE 36 CANADA CYCLODEXTRINS IN PHARMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 37 MEXICO CYCLODEXTRINS IN PHARMA MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 38 MEXICO CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 39 MEXICO CYCLODEXTRIN ASSOCIATES IN CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 40 MEXICO CYCLODEXTRIN CONJUGATES IN CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 41 MEXICO MUCOADHESIVE DRUG CARRIERS IN CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 42 MEXICO AMPHIPHILIC CYCLODEXTRINS IN CYCLODEXTRINS IN PHARMA MARKET, BY STRUCTURE, 2018-2027 (USD THOUSAND)

TABLE 43 MEXICO CYCLODEXTRINS IN PHARMA MARKET, BY NATURE, 2018-2027 (USD THOUSAND)

TABLE 44 MEXICO CYCLODEXTRINS IN PHARMA MARKET, BY FORM, 2018-2027 (USD THOUSAND)

TABLE 45 MEXICO CYCLODEXTRINS IN PHARMA MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 46 MEXICO CYCLODEXTRINS IN PHARMA MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)

TABLE 47 MEXICO CYCLODEXTRINS IN PHARMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions